# FDA 483 - Tamar F. Brionez, M.D. - May 07, 2026

Source: https://www.keypedia.com/records/483/tamar-f-brionez-md/0288f5cf-b8d4-4c3d-9a38-e7a35f5a2e9e

> FDA 483 for Tamar F. Brionez, M.D. on May 07, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Tamar F. Brionez, M.D.
- Inspection Date: 2026-05-07
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: Tamar F. Brionez, M.D., a clinical investigator in The Woodlands, TX, received a Form 483 for significant issues during an FDA inspection. Observations included failure to conduct an investigation according to the investigational plan, with subjects missing scheduled visits and protocol deviations not being reported. Additionally, the firm failed to maintain adequate case histories, lacking original source documentation for key data points necessary to verify study accuracy and reliability.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/vidhi-j-jani/2e8e2811-bcb6-49dc-8c36-bd3ed73874cf)

Company: https://www.keypedia.com/companies/tamar-f-brionez-md/22b08381-25ad-48f6-9b91-1df85f544985

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab